Pharma stock announces 6,560% dividend after Q4 results
Abbott India Ltd announced a significant 6,560% dividend after reporting Q4 FY26 results with revenue at ₹1,710 cr and EBITDA up 3.9% to ₹481 cr. Despite a 3.29% drop in share price, it has returned 67% over five years.
after close1 source ↓written by the desknot a recommendation
- following its Q4
- 6,560% dividend
- QoQ decline
- 0.8%
- EBITDA rose
- 3.9%
- ₹481 cr
- cap stands
- ₹57,534 cr
A major subsidiary of Abbott Laboratories announced a 6,560% dividend following its Q4 FY26 results, which showed revenue of ₹1,710 cr despite a slight QoQ decline of 0.8%. EBITDA rose 3.9% to ₹481 cr, reflecting steady profit growth. The stock's market cap stands at ₹57,534 cr. 📈
The share price fell 3.29% to ₹26,861.55, but has delivered a 67% return over five years, indicating potential resilience in the long term.
Not investment advice. For informational purposes only.